Annovis Stock Buy Hold or Sell Recommendation

ANVS -  USA Stock  

USD 13.04  0.49  3.62%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Annovis Bio is 'Cautious Hold'. Macroaxis provides Annovis Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ANVS positions. The advice algorithm takes into account all of Annovis Bio's available fundamental, technical, and predictive indicators you will find on this site.

Annovis Advice 

 
Refresh
The advice is provided from Annovis Bio's buy-and-hold perspective. Please continue to Annovis Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Annovis and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Annovis Bio.

Execute Annovis Bio Buy or Sell Advice

The Annovis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Annovis Bio. Macroaxis does not own or have any residual interests in Annovis Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Annovis Bio's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Annovis BioBuy Annovis Bio
Cautious Hold

Volatility

Not too volatileDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very HighDetails

Economic Sensitivity

Actively responds to the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Annovis Bio has a Mean Deviation of 4.29, Standard Deviation of 5.75 and Variance of 33.05
Our trade advice tool can cross-verify current analyst consensus on Annovis Bio and to analyze the company potential to grow in the current economic cycle. To make sure Annovis Bio is not overpriced, please confirm all Annovis Bio fundamentals, including its debt to equity, and the relationship between the revenue and number of employees . Given that Annovis Bio has a price to earning of (0.43) X, we suggest you to validate Annovis Bio market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Annovis Bio Trading Alerts and Improvement Suggestions

Annovis Bio generated a negative expected return over the last 90 days
Annovis Bio has high historical volatility and very poor performance
Annovis Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 366.66 K. Net Loss for the year was (10.28 M) with profit before overhead, payroll, taxes, and interest of 173.72 K.
Annovis Bio currently holds about 47.46 M in cash with (8.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.86.
Annovis Bio has a frail financial position based on the latest SEC disclosures
Roughly 31.0% of the company shares are held by company insiders
Latest headline from www.nasdaq.com: Insiders might want to re-evaluate their US658k stock purchase as Annovis Bio, Inc. drops to US117m - Nasdaq

Annovis Bio current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Annovis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Annovis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price70.00
Target Median Price70.00
Target High Price70.00
Recommendation Mean2.00
Number Of Analyst Opinions1
Target Low Price70.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Annovis Bio Returns Distribution Density

The distribution of Annovis Bio's historical returns is an attempt to chart the future uncertainty of Annovis Bio's future price movements. The chart of the probability distribution of Annovis Bio stock daily returns describes the distribution of returns around its average expected value. We use Annovis Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Annovis Bio returns is essential to provide solid investment advice for Annovis Bio stock.
Mean Return-1.01Value At Risk-8.23
Potential Upside11.13Standard Deviation5.75
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Annovis Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Annovis Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Annovis Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Annovis Bio backward and forwards among themselves. Annovis Bio's institutional investor refers to the entity that pools money to purchase Annovis Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares229.5 K7.3 M
Voloridge Investment Management LlcCommon Shares108.7 K3.5 M
Blackrock IncCommon Shares103.3 K3.3 M
Two Sigma Investments LpCommon Shares97.6 K3.1 M
Aigh Capital Management LlcCommon Shares66.5 K2.1 M
Millennium Management LlcCommon Shares65.6 K2.1 M
Wescott Financial Advisory Group LlcCommon Shares41.6 K1.3 M
Note, although Annovis Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Annovis Bio Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Annovis Bio or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Annovis Bio stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Annovis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.91
β
Beta against DOW1.85
σ
Overall volatility
5.80
Ir
Information ratio -0.17

Annovis Bio Volatility Alert

Annovis Bio exhibits very low volatility with skewness of 0.79 and kurtosis of 1.49. However, we advise investors to further study Annovis Bio technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Annovis Bio's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Annovis Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Annovis Bio Implied Volatility

Annovis Bio's implied volatility exposes the market's sentiment of Annovis Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Annovis Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Annovis Bio stock will not fluctuate a lot when Annovis Bio's options are near their expiration.

Annovis Bio Fundamentals Vs Peers

Comparing Annovis Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Annovis Bio's direct or indirect competition across all of the common fundamentals between Annovis Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Annovis Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Annovis Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Annovis Bio by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Annovis Bio to competition
FundamentalsAnnovis BioPeer Average
Return On Equity(36.93) %(0.31) %
Return On Asset(23.06) %(0.14) %
Current Valuation105.32 M16.62 B
Shares Outstanding8.1 M571.82 M
Shares Owned by Insiders30.67 %10.09 %
Shares Owned by Institutions18.55 %39.21 %
Number of Shares Shorted428.35 K4.71 M
Price to Earning(0.43) X28.72 X
Price to Book2.27 X9.51 X
Price to Sales2.33 X11.42 X
Revenue366.66 K9.43 B
Gross Profit173.72 K27.38 B
EBITDA(2.1 M)3.9 B
Net Income(10.28 M)570.98 M
Cash and Equivalents47.46 M2.7 B
Cash per Share5.86 X5.01 X
Debt to Equity(0.31) %48.70 %
Current Ratio42.52 X2.16 X
Book Value Per Share5.74 X1.93 K
Cash Flow from Operations(8.13 M)971.22 M
Short Ratio3.21 X4.00 X
Earnings Per Share(1.40) X3.12 X
Number of Employees218.84 K
Beta5.74-0.15
Market Capitalization105.63 M19.03 B
Total Asset1.93 M29.47 B
Retained Earnings(9.47 M)9.33 B
Working Capital770 K1.48 B
Current Asset986 K9.34 B
Current Liabilities216 K7.9 B
Z Score-8.98.72
   Exercise or conversion by Maccecchini Marialuisa of 32959 shares of Annovis Bio subject to Rule 16b-3 [view details]

Annovis Bio Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Annovis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution6605.42
Daily Balance Of Power(0.70)
Rate Of Daily Change0.96
Day Median Price13.31
Day Typical Price13.22
Market Facilitation Index0.0
Price Action Indicator(0.52)

About Annovis Bio Buy or Sell Advice

When is the right time to buy or sell Annovis Bio? Buying financial instruments such as Annovis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Annovis Bio investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets747.51 K8.12 M9.34 M10.07 M
Total Assets1.12 M8.12 M9.34 M10.07 M

Use Investing Ideas to Build Portfolios

In addition to having Annovis Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Thematic Idea Now

Small Growth
Small Growth Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. Small Growth theme has 40 constituents.
View All  Next Launch Small Growth
Please continue to Annovis Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.